» Articles » PMID: 1472994

Phosphate Analysis and Dephosphorylation of Modified Tau Associated with Paired Helical Filaments

Overview
Journal Brain Res
Specialty Neurology
Date 1992 Dec 4
PMID 1472994
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

We performed phosphate analysis of tau proteins isolated from normal human brain, tau proteins associated with paired helical filaments (PHF-tau), and Alzheimer tau not associated with PHF. These tau fractions were of high purity. Normal and Alzheimer tau were purified by heat treatment, acid extraction and calmodulin-affinity chromatography with or without HPLC. Fractions containing primarily PHF-tau polypeptides of 60, 64 and 68 kDa and their degraded fragments were purified either on a sucrose density gradient as filaments (PHF) or by heat treatment and acid extraction as amorphous proteins (PHF-tau). PHF and PHF-tau were found to contain 6-8 mol phosphate/mol protein while normal and Alzheimer tau proteins contained 1.9 and 2.6 mol phosphate/mol protein, respectively. Upon 2-h incubation with alkaline phosphatase, PHF lost two of the phosphate groups without apparent changes in the stability and morphology of PHF. The released phosphate originated from the N-terminal half of PHF-tau as determined by immunoblotting with antibodies to epitopes blocked by phosphorylation. Tau-1 and E-2, and by a prominent shift in the electrophoretic mobility of some fragments of PHF-tau. The shift in mobility was not observed with the C-terminal fragments of 25-26 kDa, which retained the epitope to Tau 46. The results suggest that the phosphorylation sites not affected by phosphatase may be located in the 25-26 kDa C-terminal region of PHF-tau and may play a role in structural stability of PHF.

Citing Articles

Natural products against tau hyperphosphorylation-induced aggregates: Potential therapies for Alzheimer's disease.

Basurto-Islas G, Diaz M, Ocampo L, Martinez-Herrera M, Lopez-Camacho P Arch Pharm (Weinheim). 2025; 358(1):e2400721.

PMID: 39888017 PMC: 11781347. DOI: 10.1002/ardp.202400721.


Targeting amyloid proteins for clinical diagnosis of neurodegenerative diseases.

Zhang S, Dong H, Bian J, Li D, Liu C Fundam Res. 2024; 3(4):505-519.

PMID: 38933553 PMC: 11197785. DOI: 10.1016/j.fmre.2022.10.009.


Quantification of Methylation and Phosphorylation Stoichiometry.

Ayoub C, Moore K, Kuret J Methods Mol Biol. 2024; 2754:221-235.

PMID: 38512670 DOI: 10.1007/978-1-0716-3629-9_13.


Interaction of Tau with G-Protein-Coupled Purinergic P2Y12 Receptor by Molecular Docking and Molecular Dynamic Simulation.

Chidambaram H, Desale S, Chinnathambi S Methods Mol Biol. 2024; 2754:33-54.

PMID: 38512659 DOI: 10.1007/978-1-0716-3629-9_2.


Tau oligomerization on microtubules in health and disease.

Ori-McKenney K, McKenney R Cytoskeleton (Hoboken). 2023; 81(1):35-40.

PMID: 37747123 PMC: 10841430. DOI: 10.1002/cm.21785.